Warning: The NCBI web site requires JavaScript to function. more...
Recent advances in systemic therapy: new diagnostics and biological predictors of outcome in early breast cancer.
Oakman C, Bessi S, Zafarana E, Galardi F, Biganzoli L, Di Leo A.
Breast Cancer Res. 2009;11(2):205. Epub 2009 Apr 3. Review.
Related citations
Genomic predictors of outcome and treatment response in breast cancer.
Dunn L, Demichele A.
Mol Diagn Ther. 2009;13(2):73-90. doi: 10.2165/01250444-200913020-00002. Review.
Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.
Adv Exp Med Biol. 2007;608:1-22. Review.
Gene-expression assays: new tools to individualize treatment of early-stage breast cancer.
Dobbe E, Gurney K, Kiekow S, Lafferty JS, Kolesar JM.
Am J Health Syst Pharm. 2008 Jan 1;65(1):23-8. Review.
Recent advances in systemic therapy: advances in adjuvant systemic chemotherapy of early breast cancer.
López-Tarruella S, Martín M.
Breast Cancer Res. 2009;11(2):204. Epub 2009 Mar 19. Review.
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.
Impact of gene expression profiling tests on breast cancer outcomes.
Marchionni L, Wilson RF, Marinopoulos SS, Wolff AC, Parmigiani G, Bass EB, Goodman SN.
Evid Rep Technol Assess (Full Rep). 2007 Dec;(160):1-105. Review.
Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.
Ross JS.
Adv Anat Pathol. 2009 Jul;16(4):204-15. Review.
Breast cancer prognostication and prediction: are we making progress?
Lønning PE.
Ann Oncol. 2007 Sep;18 Suppl 8:viii3-7. Review.
Breast cancer assessment tools and optimizing adjuvant therapy.
Oakman C, Santarpia L, Di Leo A.
Nat Rev Clin Oncol. 2010 Dec;7(12):725-32. Epub 2010 Oct 26. Review.
Gene expression profiling in breast cancer.
Morris SR, Carey LA.
Curr Opin Oncol. 2007 Nov;19(6):547-51. Review.
The curability of breast cancer and the treatment of advanced disease.
Guarneri V, Conte PF.
Eur J Nucl Med Mol Imaging. 2004 Jun;31 Suppl 1:S149-61. Epub 2004 Apr 24. Review.
Commercialized multigene predictors of clinical outcome for breast cancer.
Ross JS, Hatzis C, Symmans WF, Pusztai L, Hortobágyi GN.
Oncologist. 2008 May;13(5):477-93. Review. Erratum in: Oncologist. 2008 Aug;13(8). doi: 10.1634/theoncologist.2007-0248.
Factors predictive of response to hormone therapy in breast cancer.
Rastelli F, Crispino S.
Tumori. 2008 May-Jun;94(3):370-83. Review.
Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.
Malinowski DP.
Expert Rev Mol Diagn. 2007 May;7(3):269-80. Review.
Molecular prediction of the therapeutic response to neoadjuvant chemotherapy in breast cancer.
Nagasaki K, Miki Y.
Breast Cancer. 2008;15(2):117-20. Review.
Systematic review: gene expression profiling assays in early-stage breast cancer.
Marchionni L, Wilson RF, Wolff AC, Marinopoulos S, Parmigiani G, Bass EB, Goodman SN.
Ann Intern Med. 2008 Mar 4;148(5):358-69. Epub 2008 Feb 4. Review.
Metastatic breast cancer: an updating.
Nicolini A, Giardino R, Carpi A, Ferrari P, Anselmi L, Colosimo S, Conte M, Fini M, Giavaresi G, Berti P, Miccoli P.
Biomed Pharmacother. 2006 Nov;60(9):548-56. Epub 2006 Aug 28. Review.
Biomolecular features of clinical relevance in breast cancer.
Daidone MG, Paradiso A, Gion M, Harbeck N, Sweep F, Schmitt M.
Eur J Nucl Med Mol Imaging. 2004 Jun;31 Suppl 1:S3-14. Epub 2004 Apr 17. Review.
Prognostic and predictive factors and genetic analysis of early breast cancer.
Martín M, González Palacios F, Cortés J, de la Haba J, Schneider J.
Clin Transl Oncol. 2009 Oct;11(10):634-42. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on